tradingkey.logo

Stryker Corp

SYK
View Detailed Chart
369.320USD
-0.270-0.07%
Close 10/30, 16:00ETQuotes delayed by 15 min
141.19BMarket Cap
48.39P/E TTM

Stryker Corp

369.320
-0.270-0.07%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.07%

5 Days

-4.90%

1 Month

-0.15%

6 Months

-0.43%

Year to Date

+2.57%

1 Year

+2.87%

View Detailed Chart

TradingKey Stock Score of Stryker Corp

Currency: USD Updated: 2025-10-29

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Stryker Corp's Score

Industry at a Glance

Industry Ranking
28 / 210
Overall Ranking
99 / 4623
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 33 analysts
Buy
Current Rating
430.908
Target Price
+14.62%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Stryker Corp Highlights

StrengthsRisks
Stryker Corporation (Stryker) is a medical technology company. It offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products. It also develops neurointerventional devices for the treatment of intracranial aneurysms. It offers Fortress, a modular wall system for hospitals and ambulatory surgery centers. It specializes in soft tissue fixation products and delivering AI-assisted virtual care workflows.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.47% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 22.59B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 41.30%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 41.30%.
Overvalued
The company’s latest PE is 48.34, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 313.08M shares, decreasing 1.55% quarter-over-quarter.
Held by Jerome Dodson | PARNX
Star Investor Jerome Dodson | PARNX holds 1.58M shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Stryker Corp Info

Stryker Corporation (Stryker) is a medical technology company. It offers products and services in Medical and Surgical, Neurotechnology, Orthopedics and Spine that help improve patient and healthcare outcomes. It operates through two segments: MedSurg and Neurotechnology, and Orthopedics and Spine. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; clinical communication and workflow solutions; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products. It also develops neurointerventional devices for the treatment of intracranial aneurysms. It offers Fortress, a modular wall system for hospitals and ambulatory surgery centers. It specializes in soft tissue fixation products and delivering AI-assisted virtual care workflows.
Ticker SymbolSYK
CompanyStryker Corp
CEOMr. Kevin A. Lobo
Websitehttps://www.stryker.com/
KeyAI